FM-IL2 CAR T cells for Pancreatic Cancer Post author: Post published:April 22, 2025 Post category: Continue ReadingFM-IL2 CAR T cells for Pancreatic Cancer
Lep001 – gene therapy for the treatment of congenital lipodystrophy Post author: Post published:April 22, 2025 Post category: Continue ReadingLep001 – gene therapy for the treatment of congenital lipodystrophy
Development of an off-the-shelf iPSC derived CAR T cell therapy for the treatment of solid tumors Post author: Post published:April 22, 2025 Post category: Continue ReadingDevelopment of an off-the-shelf iPSC derived CAR T cell therapy for the treatment of solid tumors
Development of an AAV Epigenetic Gene Therapy for Gain-of-Function SCN9A Disorders and Chronic Pain Post author: Post published:April 22, 2025 Post category: Continue ReadingDevelopment of an AAV Epigenetic Gene Therapy for Gain-of-Function SCN9A Disorders and Chronic Pain
Evaluation of an ex vivo lentiviral gene therapy for the treatment of Angelman syndrome Post author: Post published:April 22, 2025 Post category: Continue ReadingEvaluation of an ex vivo lentiviral gene therapy for the treatment of Angelman syndrome
Genetic Therapy Targeting mHTT mRNA and Somatic Expansion to Treat Huntington’s Disease Post author: Post published:April 22, 2025 Post category: Continue ReadingGenetic Therapy Targeting mHTT mRNA and Somatic Expansion to Treat Huntington’s Disease
A Novel Gene Therapy to Target Glioblastoma via Custom-Engineered Adenovirus-Associated Viral Vectors Post author: Post published:April 22, 2025 Post category: Continue ReadingA Novel Gene Therapy to Target Glioblastoma via Custom-Engineered Adenovirus-Associated Viral Vectors
Parkin Gene Therapy for Parkinson’s Disease Post author: Post published:April 22, 2025 Post category: Continue ReadingParkin Gene Therapy for Parkinson’s Disease
A novel non-genotoxic antibody conditioning therapeutic to expand access to and safety of HSCT and CD34+ gene therapies Post author: Post published:April 22, 2025 Post category: Continue ReadingA novel non-genotoxic antibody conditioning therapeutic to expand access to and safety of HSCT and CD34+ gene therapies
Hematopoietic Stem Cell Gene Therapy for Alpha Thalassemia Post author: Post published:April 22, 2025 Post category: Continue ReadingHematopoietic Stem Cell Gene Therapy for Alpha Thalassemia